Evidence map›Paper›PMID 22573675›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice.

Mu Yang, Ozlem Bozdagi, Maria Luisa Scattoni, Markus Wöhr, Florence I Roullet, Adam M Katz, Danielle N Abrams, David Kalikhman, Harrison Simon, Leuk Woldeyohannes and 6 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 238 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
238citing papers in PubMed, 2 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

238 citing papers in PubMed, 2 syntheses or guidelines pooled it, 378 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Cancers · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. A neuron type-specific microexon inbioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. A Frank Assessment of SHANK: Impacts of Pathogenic Variations in SHANK3 on Preclinical Models of Phelan McDermid Syndrome.Autism research : official journal of the International Society for Autism Research · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article

178 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 4 countries.

Mu YangLaboratory of Behavioral Neuroscience, National Institute of Mental Health, Bethesda, MD 20892, USA. yangmu@mail.nih.gov
Ozlem Bozdagi
Maria Luisa Scattoni
Markus Wöhr
Florence I Roullet
Adam M Katz
Danielle N Abrams
David Kalikhman
Harrison Simon
Leuk Woldeyohannes
James Y Zhang
Mark J Harris
Roheeni Saxena
Jill L Silverman
Joseph D Buxbaum
Jacqueline N Crawley
National Institutes of Health · USNational Institute of Mental Health · USIcahn School of Medicine at Mount Sinai · USPhilipps University of Marburg · DE

Funding

Animal Models Of Neuropsychiatric DisordersZIAMH002179 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI CRAWLEY, JACQUELINE N · 2009 to 2012
$6.4M
Identifying therapeutic targets for autism using Shank3-deficient miceR01MH093725 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUXBAUM, JOSEPH D. · 2011 to 2015
$2.5M
Intramural NIH HHS Z99 MH999999NIMH NIH HHS R01 MH093725
6 · The paper itself

Abstract

Mutations in the synaptic scaffolding protein gene SHANK3 are strongly implicated in autism and Phelan-McDermid 22q13 deletion syndrome. The precise location of the mutation within the Shank3 gene is key to its phenotypic outcomes. Here, we report the physiological and behavioral consequences of null and heterozygous mutations in the ankyrin repeat domain in Shank3 mice. Both homozygous and heterozygous mice showed reduced glutamatergic transmission and long-term potentiation in the hippocampus with more severe deficits detected in the homozygous mice. Three independent cohorts were evaluated for magnitude and replicability of behavioral endophenotypes relevant to autism and Phelan-McDermid syndrome. Mild social impairments were detected, primarily in juveniles during reciprocal interactions, while all genotypes displayed normal adult sociability on the three-chambered task. Impaired novel object recognition and rotarod performance were consistent across cohorts of null mutants. Repetitive self-grooming, reduced ultrasonic vocalizations, and deficits in reversal of water maze learning were detected only in some cohorts, emphasizing the importance of replication analyses. These results demonstrate the exquisite specificity of deletions in discrete domains within the Shank3 gene in determining severity of symptoms.

Indexed as

PhenotypeAge FactorsAnimalsAutistic DisorderCarrier ProteinsExcitatory Postsynaptic PotentialsFemaleGenetic Carrier ScreeningGlutamic AcidHomozygoteMaleMiceMice, Inbred C57BLMice, KnockoutMicrofilament ProteinsMutationCarrier ProteinsGlutamic AcidMicrofilament ProteinsNerve Tissue ProteinsShank3 protein, mouse

Identifiers

PMID22573675
PMCPMC3362928
OpenAlexW2054356301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.